HOME › DRUGS › DEUCRAVACITINIB
ACTIVE SUBSTANCE / INN

DEUCRAVACITINIB

Brand name(s): SOTYKTU, Sotyktu
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Psoriasis
NDA214958
ACTIVE SUBSTANCE
Deucravacitinib
REGULATORS
FDA · EMA
SPONSORS / MAH
BRISTOL, Bristol-Myers Squibb Pharma EEIG
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SOTYKTUNDA214958BRISTOLPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SotyktuBristol-Myers Squibb Pharma EEIGAuthorised24/03/2023Psoriasis

FULL INTELLIGENCE ON DEUCRAVACITINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →